Our professionals

Imagen Dra. Leire Arbea Moreno, Departamento de Oncologia Radioterapica.

Dr. Leire Arbea Moreno

Specialist in Radiation Oncology
Preferential dedication to gastrointestinal and hepatobiliary tumors

Works at: Navarre headquarters
Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra

Professional career

Graduated (1999) and Doctor (2011) in Medicine and Surgery by the University of Navarra.

Specialist in Radiation Oncology by the University of Navarra Clinic (2003). 

Coordinator of the Gastrointestinal Tumors area of the Department of Oncology (2014)

Master in Molecular Oncology by the National Center for Oncological Research (CNIO) (2014)

RESEARCH AREAS

Author of more than 25 articles indexed in national and international scientific journals of the specialty. Co-author of 10 chapters of specialized books.

AREAS OF INTEREST

  • Treatment of gastrointestinal and hepatobiliary tumors.
  • Translational research in Radiation Oncology.

Activity

As an educator

  • Professor hired via ANECA in 2013
  • Associate Professor of the Faculty of Medicine of the University of Navarra
  • Clinical tutoring of medical students
  • Professor of the Pre-clinical course taught in the Undergraduate program of the School of Medicine of the University of Navarra
  • Member of the Commission of the Medical Education Unit of the Medical School of the University of Navarra
  • Professor of the Certificate of Medical Education, a degree from the University of Navarra
  • Professor of the Master of Advanced Technological Applications in Radiation Oncology at the Madrid Institute of Oncology

As a researcher

Author of more than 25 articles indexed in national and international scientific journals of the specialty. Co-author of 10 chapters of specialized books.

Imagen de un icono azul con un documento certificado.

Awards

Extraordinary doctoral award for the thesis "Intensity-modulated radiation therapy, capecitabine and oxaliplatin in the treatment of locally advanced rectal cancer: preclinical study, phase I-II study and phase II validation study" .

Scientific organizations

  • Member of the Spanish Society of Radiation Oncology.
  • Member of the gastrointestinal group of the Spanish Society of Radiation Oncology (SEORGI).
  • Member of the ALIANZA group for the prevention of colon cancer in Spain.